Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atorvastatin-containing Treatment Regimens for Pulmonary Tuberculosis: A Randomized, Open-label, Controlled phase2C/3 Clinical Trial

NCT06199921 is registered in ClinicalTrials.gov with Obafemi Awolowo University Teaching Hospital as lead sponsor.

NCT NCT06199921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06199921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atorvastatin-containing Treatment Regimens for Pulmonary Tuberculosis: A Randomized, Open-label, Controlled phase2C/3 Clinical Trial
Lead sponsor
Obafemi Awolowo University Teaching Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
January 3, 2024
Completion date
September 30, 2026
Enrollment
440 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

koch's disease, pulmonary tuberculosis, tuberculosis